Impact of systemic lupus erythematosus disease activity, hydroxychloroquine and NSAID on the risk of subsequent organ system damage and death: analysis in a single US medical centre
Objective To assess the impact of mild-moderate systemic lupus erythematosus (SLE) disease activity during a 12-month period on the risk of death or subsequent organ system damage.Methods 1168 patients with ≥24 months of follow-up from the Hopkins Lupus Cohort were included. Disease activity in a 12...
Saved in:
Main Authors: | Qinggong Fu, Amanda M Eudy, Deanna D Hill, Peter J Egger |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-04-01
|
Series: | Lupus Science and Medicine |
Online Access: | https://lupus.bmj.com/content/8/1/e000446.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Successful treatment of cardiac tamponade with systemic lupus erythematosus using belimumab and hydroxychloroquine
by: Tomoo Kise, et al.
Published: (2023-01-01) -
Hydroxychloroquine is associated with lower platelet activity and improved vascular health in systemic lupus erythematosus
by: Peter Izmirly, et al.
Published: (2021-04-01) -
Life Threatening Severe QTc Prolongation in Patient with Systemic Lupus Erythematosus due to Hydroxychloroquine
by: John P. O’Laughlin, et al.
Published: (2016-01-01) -
Efficacy of Hydroxychloroquine for Improving Pregnancy Outcomes in a Female with Systemic Lupus Erythematosus and Antiphospholipid Syndrome
by: Yumika Takaki, et al.
Published: (2022-01-01) -
Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus
by: Luis M Vila, et al.
Published: (2020-10-01)